41 related articles for article (PubMed ID: 19933898)
1. Hodgkin's lymphoma: 2023 update on treatment.
Zhang S; Liu X; Li L; Qiu L; Qian Z; Zhou S; Wang X; Zhang H
Cancer Biol Med; 2023 Dec; 21(4):269-73. PubMed ID: 38164723
[No Abstract] [Full Text] [Related]
2. Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome.
Savage KJ; Skinnider B; Al-Mansour M; Sehn LH; Gascoyne RD; Connors JM
Blood; 2011 Oct; 118(17):4585-90. PubMed ID: 21873543
[TBL] [Abstract][Full Text] [Related]
3. Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up.
Pugliese N; Picardi M; Della Pepa R; Giordano C; Muriano F; Leone A; Delle Cave G; D'Ambrosio A; Marafioti V; Rascato MG; Russo D; Mascolo M; Pane F
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917062
[TBL] [Abstract][Full Text] [Related]
4. The stage-specific roles of radiotherapy and chemotherapy in nodular lymphocyte predominant Hodgkin lymphoma patients: a propensity score-matched analysis of the SEER database.
Wang S; Jia M; Han J; Zhang R; Huang K; Qiao Y; Chen P; Fu Z
Cancer Med; 2021 Jan; 10(2):540-551. PubMed ID: 33249743
[TBL] [Abstract][Full Text] [Related]
5. Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma.
Fanale MA; Cheah CY; Rich A; Medeiros LJ; Lai CM; Oki Y; Romaguera JE; Fayad LE; Hagemeister FB; Samaniego F; Rodriguez MA; Neelapu SS; Lee HJ; Nastoupil L; Fowler NH; Turturro F; Westin JR; Wang ML; McLaughlin P; Pinnix CC; Milgrom SA; Dabaja B; Horowitz SB; Younes A
Blood; 2017 Jul; 130(4):472-477. PubMed ID: 28522441
[TBL] [Abstract][Full Text] [Related]
6. Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study.
Lazarovici J; Dartigues P; Brice P; Obéric L; Gaillard I; Hunault-Berger M; Broussais-Guillaumot F; Gyan E; Bologna S; Nicolas-Virelizier E; Touati M; Casasnovas O; Delarue R; Orsini-Piocelle F; Stamatoullas A; Gabarre J; Fornecker LM; Gastinne T; Peyrade F; Roland V; Bachy E; André M; Mounier N; Fermé C
Haematologica; 2015 Dec; 100(12):1579-86. PubMed ID: 26430172
[TBL] [Abstract][Full Text] [Related]
7. Nodular Lymphocyte Predominant Hodgkin Lymphoma versus T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Diagnostic Challenge.
Rets AV; Gottesman SR
Case Rep Pathol; 2014; 2014():956217. PubMed ID: 25110597
[TBL] [Abstract][Full Text] [Related]
8. Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group.
Appel BE; Chen L; Buxton A; Wolden SL; Hodgson DC; Nachman JB
Pediatr Blood Cancer; 2012 Dec; 59(7):1284-9. PubMed ID: 22847767
[TBL] [Abstract][Full Text] [Related]
9. The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma.
Maeda LS; Advani RH
Curr Opin Oncol; 2009 Sep; 21(5):397-400. PubMed ID: 19606035
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of recurrent Hodgkin's lymphoma. I. Radiotherapy and conventional chemotherapy].
Pfreundschuh M; Diehl V
Dtsch Med Wochenschr; 1989 Jun; 114(22):880-4. PubMed ID: 2656184
[No Abstract] [Full Text] [Related]
11. What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma?
Canellos GP; Mauch P
J Clin Oncol; 2010 Jan; 28(1):e8. PubMed ID: 19933898
[No Abstract] [Full Text] [Related]
12. Lymphocyte-predominant Hodgkin's lymphoma.
Horwich A; Cunningham D
J Clin Oncol; 2010 Jul; 28(19):e325; author reply e326. PubMed ID: 20516449
[No Abstract] [Full Text] [Related]
13. Lymphocyte-predominant Hodgkin's disease: how little therapy is enough?
Aster JC
J Clin Oncol; 1999 Mar; 17(3):744-6. PubMed ID: 10071261
[No Abstract] [Full Text] [Related]
14. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
